Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × enfortumab vedotin × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 9 Urinary Bladder Neoplasms 3 Urethral Neoplasms 1 Ureteral Neoplasms 1 Peripheral Nervous System Diseases 1 Neoplasm Metastasis 1 Muscle-invasive Bladder Cancer 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Metastatic Urothelial Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Bladder Cancer 1

Interventions

Bevacizumab 13 atezolizumab 12 Specimen Handling 9 Nivolumab 8 durvalumab 6 pembrolizumab 4 X-Rays 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 lenvatinib 3 Sorafenib 3 Immunoglobulin G 3 E-7386 3 Cyclophosphamide 3 Blood Specimen Collection 3 sintilimab 2 regorafenib 2 cabozantinib 2 Disulfides 2 Biopsy 2 tremelimumab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 sargramostim 1 sapanisertib 1 rocakinogene sifuplasmid 1 relatlimab 1 recombinant interferon alpha 2b-like protein 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡